Activation of the PI3K pathway and prognostic information in epithelial ovarian cancer.

被引:0
|
作者
Handolias, D. D. [1 ]
Chan, P. [1 ]
Phillips, W. [1 ]
Fox, S. B. [1 ]
Pearson, R. [1 ]
Sawyer, S. [1 ]
Campbell, I. [1 ]
Salemi, R. [1 ]
McArthur, G. A. [1 ]
机构
[1] Peter MacCallum Canc Ctr, Melbourne, Vic, Australia
关键词
D O I
10.1200/jco.2010.28.15_suppl.10610
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
10610
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Integrated Signature of PI3K Pathway Activation in Prostate Cancer.
    Martin, N. E.
    Sinnott, J. A.
    Finn, S.
    Fedele, G.
    Stampfer, M. J.
    Andren, O.
    Andersson, S-O
    Mucci, L.
    Loda, M.
    [J]. MODERN PATHOLOGY, 2011, 24 : 444A - 445A
  • [2] Integrated Signature of PI3K Pathway Activation in Prostate Cancer.
    Martin, N. E.
    Sinnott, J. A.
    Finn, S.
    Fedele, G.
    Stampfer, M. J.
    Andren, O.
    Andersson, S-O
    Mucci, L.
    Loda, M.
    [J]. LABORATORY INVESTIGATION, 2011, 91 : 444A - 445A
  • [3] Drugging the PI3K pathway in cancer.
    Workman, P
    [J]. CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6276S - 6277S
  • [4] The Development of PI3K Pathway Modulators for Cancer.
    Sellers, W. R.
    [J]. CANCER RESEARCH, 2009, 69 (24) : 484S - 484S
  • [5] Bimodal ntrk expression and correlation with activation of PI3K/AKT pathway in lung cancer.
    Ma, Wanlong
    De Dios, Ivan
    Antzoulatos, Spiraggelos
    Estella, Jeffrey
    Albitar, Maher
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [6] Targeting the PI3K/AKT/mTOR pathway in ovarian cancer
    Musa, Fernanda
    Schneider, Robert
    [J]. TRANSLATIONAL CANCER RESEARCH, 2015, 4 (01) : 97 - 106
  • [7] PI3K pathway activation and thromboembolism in ovarian clear cell carcinomas
    Diaz, E.
    Fleming, N.
    Nassanian, H.
    Walts, A.
    Zajchowski, D.
    Orsulic, S.
    Walsh, C.
    [J]. GYNECOLOGIC ONCOLOGY, 2012, 127 (01) : S1 - S2
  • [8] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    [J]. CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
  • [9] PI3K inhibitors as a backbone for combination treatments for breast and ovarian cancer.
    Wulf, Gerburg
    Konstantinopoulos, Panos
    Barry, William
    Sonzongi, Olmo
    Eismann, Julia
    Kucherlapati, Bose
    Matulonis, Ursula
    [J]. MOLECULAR CANCER RESEARCH, 2020, 18 (10) : 22 - 22
  • [10] The Role of the PTEN/PI3K/Akt Pathway on Prognosis in Epithelial Ovarian Cancer: AMeta-Analysis
    Cai, Jing
    Xu, Linjuan
    Tang, Huijuan
    Yang, Qiang
    Yi, Xiaoqing
    Fang, Yan
    Zhu, Ying
    Wang, Zehua
    [J]. ONCOLOGIST, 2014, 19 (05): : 528 - 535